United Therapeutics Corporation · NASDAQ:UTHR

Edgemond James sold 10,000 United Therapeutics Corporation shares (Form 4)

Traded Jun 8, 2026 · Filed Jun 9, 2026

On Jun 8, 2026, Edgemond James (CFO AND TREASURER) sold 10,000 United Therapeutics Corporation shares at an average US$547.50 for US$5.48M under a trading plan, leaving 18,876 shares. Filed Jun 9, 2026 (Form 4).

Sold
10,000 shares
Price
US$547.50 average (US$544.93 to US$551.76)
Value
US$5.48M
Holding after
18,876 shares
Trading plan
Yes (Made under a plan set in advance)
Role
CFO AND TREASURER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 8, 2026Common StockOption exercise10,000US$117.7628,876Direct
Jun 8, 2026Common StockSale1,565US$544.9327,311Direct
Jun 8, 2026Common StockSale1,989US$546.1325,322Direct
Jun 8, 2026Common StockSale1,888US$547.0323,434Direct
Jun 8, 2026Common StockSale2,158US$547.9121,276Direct
Jun 8, 2026Common StockSale425US$549.3820,851Direct
Jun 8, 2026Common StockSale1,285US$550.0919,566Direct
Jun 8, 2026Common StockSale610US$551.2818,956Direct
Jun 8, 2026Common StockSale80US$551.7618,876Direct

Source

View original at SEC

Related